Fundz

J3 Bioscience

SALT LAKE CITY, Utah, United States · Healthcare, Health Care, Information Technology

J3 Bioscience is a developer of biomedical devices intended to help improve female reproductive health. The company's device is a lubricating intravaginal ring (IVR) that continuously delivers moisture and contains no hormones or drugs. It is also long-lasting, up to 7 days, enabling women to maintain vaginal health. The IVR is a personallubrication device for vaginal application intended to moist

Key facts

Headquarters
SALT LAKE CITY, Utah, United States
Employees
10
Industries
Healthcare, Health Care, Information Technology
Status
Private
Website
j3bio.com
LinkedIn
Company page

Recent activity at J3 Bioscience

J3 Bioscience funding history

DateRoundAmount
Oct 2026Venture$50K
Oct 2023Seed$20K
Jun 2023Seed$50K
May 2021Seed$530K
Mar 2019Venture$23K

Leadership

  • R. Tyler McCabe, Executive Officer, Director
  • Tim S. Glassett, Director
  • Jayne Carney, Director
  • Duck Lee, Director
  • Tim Glassett, Director
  • Larry Rigby, Director
  • R. McCabe, Executive Officer, Director

Verified email and direct lines for J3 Bioscience’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

J3 Bioscience in the news

Companies similar to J3 Bioscience

About J3 Bioscience: questions and answers

What does J3 Bioscience do?

J3 Bioscience is a developer of biomedical devices intended to help improve female reproductive health. The company's device is a lubricating intravaginal ring (IVR) that continuously delivers moisture and contains no hormones or drugs. It is also long-lasting, up to 7 days, enabling women to maintain vaginal health. The IVR is a personallubrication device for vaginal application intended to moist

Where is J3 Bioscience headquartered?

J3 Bioscience is headquartered in SALT LAKE CITY, Utah, United States.

How many employees does J3 Bioscience have?

J3 Bioscience has about 10 employees.

Has J3 Bioscience raised funding?

Yes. Fundz has recorded 5 funding events for J3 Bioscience. The most recent, $50K, was in Oct 2026.

What is the latest news on J3 Bioscience?

On Oct 16, 2026, J3 BIOSCIENCE

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches J3 Bioscience across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.